Does the media favor KMTS or CARL?

In the previous week, Kestra Medical Technologies had 1 more articles in the media than Carlsmed. MarketBeat recorded 2 mentions for Kestra Medical Technologies and 1 mentions for Carlsmed. Carlsmed's average media sentiment score of 0.94 beat Kestra Medical Technologies' score of 0.39 indicating that Carlsmed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Carlsmed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BLFS or CARL?

In the previous week, BioLife Solutions had 9 more articles in the media than Carlsmed. MarketBeat recorded 10 mentions for BioLife Solutions and 1 mentions for Carlsmed. Carlsmed's average media sentiment score of 0.94 beat BioLife Solutions' score of 0.31 indicating that Carlsmed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 1 Very Positive mention(s) 4 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Carlsmed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CARL or INSP?

In the previous week, Carlsmed and Carlsmed both had 1 articles in the media. Carlsmed's average media sentiment score of 0.94 beat Inspire Medical Systems' score of 0.30 indicating that Carlsmed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Carlsmed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspire Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor CARL or TNDM?

In the previous week, Tandem Diabetes Care had 1 more articles in the media than Carlsmed. MarketBeat recorded 2 mentions for Tandem Diabetes Care and 1 mentions for Carlsmed. Tandem Diabetes Care's average media sentiment score of 0.95 beat Carlsmed's score of 0.94 indicating that Tandem Diabetes Care is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Carlsmed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tandem Diabetes Care 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer CARL or AVNS?

Carlsmed presently has a consensus price target of $19.33, suggesting a potential upside of 73.10%. Given Carlsmed's stronger consensus rating and higher possible upside, equities analysts plainly believe Carlsmed is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Carlsmed 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Avanos Medical 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is CARL or AVNS more profitable?

Avanos Medical has a net margin of -10.39% compared to Carlsmed's net margin of -57.76%. Avanos Medical's return on equity of 5.39% beat Carlsmed's return on equity. Company Net Margins Return on Equity Return on Assets Carlsmed -57.76% -60.74% -29.84% Avanos Medical -10.39% 5.39% 3.97%

Does the media refer more to CARL or AVNS?

In the previous week, Carlsmed and Carlsmed both had 1 articles in the media. Avanos Medical's average media sentiment score of 1.00 beat Carlsmed's score of 0.94 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Carlsmed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avanos Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Carlsmed (CARL) Competitors

$11.17 +0.97 (+9.50%)

Closing price 06/4/2026 03:59 PM Eastern

Extended Trading

$11.17 +0.00 (+0.01%)

As of 06/4/2026 04:10 PM Eastern

Compare

CARL vs. KMTS, BLFS, INSP, TNDM, and AVNS

Should you buy Carlsmed stock or one of its competitors? MarketBeat compares Carlsmed with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Carlsmed include Kestra Medical Technologies (KMTS), BioLife Solutions (BLFS), Inspire Medical Systems (INSP), Tandem Diabetes Care (TNDM), and Avanos Medical (AVNS). These companies are all part of the "medical equipment" industry.

How does Carlsmed compare to Kestra Medical Technologies?

Kestra Medical Technologies (NASDAQ:KMTS) and Carlsmed (NASDAQ:CARL) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

Carlsmed has lower revenue, but higher earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Carlsmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$59.81M	19.96	-$113.81M	-$3.96	N/A
Carlsmed	$50.51M	6.01	-$29.63M	-$2.51	N/A

In the previous week, Kestra Medical Technologies had 1 more articles in the media than Carlsmed. MarketBeat recorded 2 mentions for Kestra Medical Technologies and 1 mentions for Carlsmed. Carlsmed's average media sentiment score of 0.94 beat Kestra Medical Technologies' score of 0.39 indicating that Carlsmed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kestra Medical Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Carlsmed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Carlsmed has a net margin of -57.76% compared to Kestra Medical Technologies' net margin of -171.87%. Carlsmed's return on equity of -60.74% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-171.87%	-65.49%	-46.39%
Carlsmed	-57.76%	-60.74%	-29.84%

Kestra Medical Technologies currently has a consensus price target of $27.40, suggesting a potential upside of 33.99%. Carlsmed has a consensus price target of $19.33, suggesting a potential upside of 73.10%. Given Carlsmed's higher possible upside, analysts plainly believe Carlsmed is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Carlsmed beats Kestra Medical Technologies on 8 of the 11 factors compared between the two stocks.

How does Carlsmed compare to BioLife Solutions?

BioLife Solutions (NASDAQ:BLFS) and Carlsmed (NASDAQ:CARL) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

BioLife Solutions has a net margin of -2.80% compared to Carlsmed's net margin of -57.76%. BioLife Solutions' return on equity of 1.81% beat Carlsmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioLife Solutions	-2.80%	1.81%	1.65%
Carlsmed	-57.76%	-60.74%	-29.84%

BioLife Solutions currently has a consensus price target of $32.00, indicating a potential upside of 18.12%. Carlsmed has a consensus price target of $19.33, indicating a potential upside of 73.10%. Given Carlsmed's higher possible upside, analysts plainly believe Carlsmed is more favorable than BioLife Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLife Solutions	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

93.2% of BioLife Solutions shares are owned by institutional investors. 2.2% of BioLife Solutions shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

BioLife Solutions has higher revenue and earnings than Carlsmed. BioLife Solutions is trading at a lower price-to-earnings ratio than Carlsmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLife Solutions	$96.21M	13.76	-$4.59M	-$0.08	N/A
Carlsmed	$50.51M	6.01	-$29.63M	-$2.51	N/A

In the previous week, BioLife Solutions had 9 more articles in the media than Carlsmed. MarketBeat recorded 10 mentions for BioLife Solutions and 1 mentions for Carlsmed. Carlsmed's average media sentiment score of 0.94 beat BioLife Solutions' score of 0.31 indicating that Carlsmed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioLife Solutions	1 Very Positive mention(s)	4 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Carlsmed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BioLife Solutions beats Carlsmed on 10 of the 13 factors compared between the two stocks.

How does Carlsmed compare to Inspire Medical Systems?

Carlsmed (NASDAQ:CARL) and Inspire Medical Systems (NYSE:INSP) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Carlsmed currently has a consensus target price of $19.33, suggesting a potential upside of 73.10%. Inspire Medical Systems has a consensus target price of $81.84, suggesting a potential upside of 94.67%. Given Inspire Medical Systems' higher possible upside, analysts clearly believe Inspire Medical Systems is more favorable than Carlsmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Inspire Medical Systems	3 Sell rating(s)	13 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.05

Inspire Medical Systems has higher revenue and earnings than Carlsmed. Carlsmed is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$50.51M	6.01	-$29.63M	-$2.51	N/A
Inspire Medical Systems	$915.25M	1.32	$145.42M	$4.49	9.36

Inspire Medical Systems has a net margin of 14.33% compared to Carlsmed's net margin of -57.76%. Inspire Medical Systems' return on equity of 10.35% beat Carlsmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-57.76%	-60.74%	-29.84%
Inspire Medical Systems	14.33%	10.35%	8.81%

94.9% of Inspire Medical Systems shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Carlsmed and Carlsmed both had 1 articles in the media. Carlsmed's average media sentiment score of 0.94 beat Inspire Medical Systems' score of 0.30 indicating that Carlsmed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Carlsmed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inspire Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Inspire Medical Systems beats Carlsmed on 11 of the 14 factors compared between the two stocks.

How does Carlsmed compare to Tandem Diabetes Care?

Carlsmed (NASDAQ:CARL) and Tandem Diabetes Care (NASDAQ:TNDM) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

Tandem Diabetes Care has a net margin of -9.20% compared to Carlsmed's net margin of -57.76%. Tandem Diabetes Care's return on equity of -53.88% beat Carlsmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-57.76%	-60.74%	-29.84%
Tandem Diabetes Care	-9.20%	-53.88%	-7.88%

Carlsmed currently has a consensus target price of $19.33, suggesting a potential upside of 73.10%. Tandem Diabetes Care has a consensus target price of $29.84, suggesting a potential upside of 53.43%. Given Carlsmed's higher probable upside, equities analysts plainly believe Carlsmed is more favorable than Tandem Diabetes Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Tandem Diabetes Care	1 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.57

Carlsmed has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Carlsmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$50.51M	6.01	-$29.63M	-$2.51	N/A
Tandem Diabetes Care	$1.01B	1.31	-$204.71M	-$1.40	N/A

In the previous week, Tandem Diabetes Care had 1 more articles in the media than Carlsmed. MarketBeat recorded 2 mentions for Tandem Diabetes Care and 1 mentions for Carlsmed. Tandem Diabetes Care's average media sentiment score of 0.95 beat Carlsmed's score of 0.94 indicating that Tandem Diabetes Care is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Carlsmed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tandem Diabetes Care	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Tandem Diabetes Care beats Carlsmed on 10 of the 14 factors compared between the two stocks.

How does Carlsmed compare to Avanos Medical?

Carlsmed (NASDAQ:CARL) and Avanos Medical (NYSE:AVNS) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

Carlsmed presently has a consensus price target of $19.33, suggesting a potential upside of 73.10%. Given Carlsmed's stronger consensus rating and higher possible upside, equities analysts plainly believe Carlsmed is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Avanos Medical	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Carlsmed has higher earnings, but lower revenue than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Carlsmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$50.51M	6.01	-$29.63M	-$2.51	N/A
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A

Avanos Medical has a net margin of -10.39% compared to Carlsmed's net margin of -57.76%. Avanos Medical's return on equity of 5.39% beat Carlsmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-57.76%	-60.74%	-29.84%
Avanos Medical	-10.39%	5.39%	3.97%

95.2% of Avanos Medical shares are held by institutional investors. 2.3% of Avanos Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Carlsmed and Carlsmed both had 1 articles in the media. Avanos Medical's average media sentiment score of 1.00 beat Carlsmed's score of 0.94 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Carlsmed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avanos Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Avanos Medical beats Carlsmed on 8 of the 14 factors compared between the two stocks.

Get Carlsmed News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CARL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CARL vs. The Competition

Export

Metric	Carlsmed	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$277.29M	$2.63B	$4.34B	$12.43B
Dividend Yield	N/A	N/A	7.93%	5.32%
P/E Ratio	-4.45	1.93	21.70	24.34
Price / Sales	6.01	463.16	232.31	106.60
Price / Cash	N/A	7.78	53.68	55.53
Price / Book	3.00	6.52	30.95	6.72
Net Income	-$29.63M	-$69.38M	$109.80M	$337.03M
7 Day Performance	-2.20%	-1.36%	-0.46%	-0.16%
1 Month Performance	25.21%	0.53%	4.54%	3.74%
1 Year Performance	N/A	39.97%	15.49%	34.34%

Carlsmed Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CARL Carlsmed	3.9047 of 5 stars	$11.17 +9.5%	$19.33 +73.1%	N/A	$277.29M	$50.51M	N/A	100
KMTS Kestra Medical Technologies	2.2946 of 5 stars	$21.26 +0.0%	$27.40 +28.9%	+3.3%	$1.24B	$59.81M	N/A	300	News Coverage
BLFS BioLife Solutions	2.3162 of 5 stars	$24.92 -1.3%	$32.00 +28.4%	+23.0%	$1.22B	$96.21M	N/A	440	Analyst Revision
INSP Inspire Medical Systems	4.0392 of 5 stars	$41.46 -3.7%	$81.84 +97.4%	-69.5%	$1.19B	$911.98M	9.23	1,333
TNDM Tandem Diabetes Care	3.0217 of 5 stars	$17.20 +2.9%	$29.16 +69.5%	-3.6%	$1.18B	$1.01B	N/A	2,500	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CARL) was last updated on 6/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Carlsmed (CARL) Competitors

CARL vs. KMTS, BLFS, INSP, TNDM, and AVNS

How does Carlsmed compare to Kestra Medical Technologies?

Summary

How does Carlsmed compare to BioLife Solutions?

Summary

How does Carlsmed compare to Inspire Medical Systems?

Summary

How does Carlsmed compare to Tandem Diabetes Care?

Summary

How does Carlsmed compare to Avanos Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CARL vs. The Competition

Carlsmed Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Carlsmed (CARL) Competitors

CARL vs. KMTS, BLFS, INSP, TNDM, and AVNS

How does Carlsmed compare to Kestra Medical Technologies?

Which has preferable earnings and valuation, KMTS or CARL?

Does the media favor KMTS or CARL?

Is KMTS or CARL more profitable?

Do analysts recommend KMTS or CARL?

Summary

How does Carlsmed compare to BioLife Solutions?

Is BLFS or CARL more profitable?

Do analysts rate BLFS or CARL?

Do insiders & institutionals have more ownership in BLFS or CARL?

Which has preferable earnings & valuation, BLFS or CARL?

Does the media favor BLFS or CARL?

Summary

How does Carlsmed compare to Inspire Medical Systems?

Do analysts prefer CARL or INSP?

Which has stronger valuation & earnings, CARL or INSP?

Is CARL or INSP more profitable?

Do insiders & institutionals hold more shares of CARL or INSP?

Does the media prefer CARL or INSP?

Summary

How does Carlsmed compare to Tandem Diabetes Care?

Is CARL or TNDM more profitable?

Do analysts recommend CARL or TNDM?

Which has preferable valuation & earnings, CARL or TNDM?

Does the media favor CARL or TNDM?

Summary

How does Carlsmed compare to Avanos Medical?

Do analysts prefer CARL or AVNS?

Which has preferable earnings & valuation, CARL or AVNS?

Is CARL or AVNS more profitable?

Do insiders & institutionals believe in CARL or AVNS?

Does the media refer more to CARL or AVNS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CARL vs. The Competition

Carlsmed Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools